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The checkpoint kinase Chk2 has a key role in delaying cell cycle progression in response to DNA damage.
Upon activation by low-dose ionizing radiation (IR), which occurs in an ataxia telangiectasia mutated (ATM)-
dependent manner, Chk2 can phosphorylate the mitosis-inducing phosphatase Cdc25C on an inhibitory site,
blocking entry into mitosis, and p53 on a regulatory site, causing G1 arrest. Here we show that the ATM-
dependent activation of Chk2 by g- radiation requires Nbs1, the gene product involved in the Nijmegen
breakage syndrome (NBS), a disorder that shares with AT a variety of phenotypic defects including chromo-
some fragility, radiosensitivity, and radioresistant DNA synthesis. Thus, whereas in normal cells Chk2 un-
dergoes a time-dependent increased phosphorylation and induction of catalytic activity against Cdc25C, in
NBS cells null for Nbs1 protein, Chk2 phosphorylation and activation are both defective. Importantly, these
defects in NBS cells can be complemented by reintroduction of wild-type Nbs1, but neither by a carboxy-
terminal deletion mutant of Nbs1 at amino acid 590, unable to form a complex with and to transport Mre11
and Rad50 in the nucleus, nor by an Nbs1 mutated at Ser343 (S343A), the ATM phosphorylation site. Chk2
nuclear expression is unaffected in NBS cells, hence excluding a mislocalization as the cause of failed Chk2
activation in Nbs1-null cells. Interestingly, the impaired Chk2 function in NBS cells correlates with the
inability, unlike normal cells, to stop entry into mitosis immediately after irradiation, a checkpoint abnor-
mality that can be corrected by introduction of the wild-type but not the S343A mutant form of Nbs1.
Altogether, these findings underscore the crucial role of a functional Nbs1 complex in Chk2 activation and
suggest that checkpoint defects in NBS cells may result from the inability to activate Chk2.
The integrity of genetic information is essential for the life
and survival of cells. Genomic lesions arising spontaneously
during DNA replication or in response to oxidative metabo-
lism or exposure to radiation or chemical mutagens need to be
recognized and repaired. Delay of cell cycle progression at
specific checkpoints provides the time necessary to prevent
replication and segregation of damaged DNA and to process
lesions (reviewed in references 52 and 57). A defective or
incorrect activation of the surveillance and repair systems can
lead to increased mutagenesis, genomic instability, and ulti-
mately cancer (for a review, see reference 13).
The Nijmegen breakage syndrome (NBS) and ataxia telan-
giectasia (AT) are rare human autosomal recessive diseases
(22, 51) exhibiting hypersensitivity to ionizing radiation (IR),
immunodeficiency, and increased predisposition to develop
cancer. NBS patients, however, do not manifest the hallmarks
of AT, i.e., cerebellar ataxia and oculocutaneous telangiecta-
sia. At the cellular level, NBS and AT patients show chromo-
some instability, hypersensitivity to genotoxic agents, and cell
cycle checkpoints defects (1, 29, 30). These similarities suggest
that ATM (AT mutated) (39) and Nbs1 (38, 51), the gene
products defective in AT and NBS, are involved in maintaining
genomic integrity, possibly by operating through a common
pathway.
Nbs1, a protein with a forkhead-associated domain and a
carboxy-terminal repeat frequently found in cell cycle regula-
tory and DNA repair proteins (11, 49), is essential for the
formation of radiation-induced nuclear foci, probably at the
sites of DNA breaks, together with Mre11 and Rad50 proteins
(6, 26). Biochemical evidence (33) and the homology with the
yeast Xrs2-Mre11-Rad50 complex (48) suggest a major role for
the human Nbs1-Mre11-Rad50 complex in double-strand
break repair and also in sensing DNA damage and recruiting
proteins with kinase activity (36, 52).
ATM is a protein kinase that shares similarities with the
phosphatidylinositol 3-kinases (39) involved in signaling path-
ways that regulate genome stability and cell cycle checkpoint
arrest after DNA damage or incomplete DNA replication. The
ATM kinase is critical for the regulation of G1, S and G2/M
checkpoints in response to genotoxic agents (21), as its activa-
tion by DNA damage leads to phosphorylation of targets pro-
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teins that mediate cell cycle arrest. The phosphorylation of p53
at serine 15 by ATM, in particular, appears relevant for the
G1-phase arrest, as this event contributes to p53 protein sta-
bilization (41) and enhanced transcriptional activation of the
cyclin-dependent kinase inhibitor p21waf1 (32). A role for Nbs1
in G1 checkpoint is controversial, since the extents of p53
accumulation and G1 arrest after radiation differ substantially
among NBS cell lines (1, 17, 29, 43, 55). ATM interacts with
and phosphorylates Nbs1 on Ser343 after IR (12, 23, 53, 56).
This event, though not involved in Nbs1, complex and focus
formation, is functionally relevant because a serine-to-alanine
change at amino acid (aa) 343 of Nbs1 only partially comple-
ments radiosensitivity and S-phase checkpoint deficiency in
NBS cells, while in normal cells it acts as dominant negative in
the activation of the S-phase checkpoint by IR.
Chk2, the mammalian homolog of Saccharomyces cerevisae
Rad53 and Schizosaccharomyces pombe Cds1, is a kinase whose
activation by DNA damage prevents entry into mitosis (27)
and into S phase (9, 14, 40). Chk2 kinase is activated by phos-
phorylation in ATM-dependent manner (5, 8, 27, 28) on thre-
onine 68 (31). In vitro, Chk2 is capable of phosphorylating all
members of the Cdc25 family, Cdc25A, -B, and -C (27).
Cdc25C, in particular, is phosphorylated by Chk2 on Ser216,
the consensus binding site for the 14-3-3 family of proteins that
regulate biochemical activities by binding to and sequestering
phosphorylated proteins (54). In homology with S. pombe, the
Cdc25C–14-3-3 interaction may prevent mitosis by sequester-
ing Cdc25C in the cytoplasm (25, 37), where it cannot dephos-
phorylate and activate Cdc2-cyclin B nuclear complexes (35).
After DNA damage, Chk2 phosphorylates p53 on Ser20 (9, 14,
40), attenuating the binding of p53 to Mdm2, a protein that
targets p53 for degradation, and allowing accumulation and
subsequent activation of p21waf1 and G1 arrest. Noteworthy,
inherited mutations of CHK2, like those of ATM and NBS1
genes, confer tumor susceptibility, according to recent findings
showing germ line CHK2 mutations in a subset of cancer-prone
Li-Fraumeni cases wild type for p53 (3), further underscoring
the function of cell cycle checkpoints in preventing genetic
instability and cancer.
In this work, we have assessed the role of Nbs1 in the
phosphorylation and activation of Chk2 kinase by using differ-
ent primary and immortalized NBS cell lines with undetectable
levels of Nbs1 protein. We show that DNA damage induces a
time-dependent increase in Chk2 phosphorylation and activa-
tion in normal but not in NBS cells. Moreover, we demonstrate
that this defect can be complemented by a functional Nbs1
nuclear complex.
MATERIALS AND METHODS
Cell lines and irradiation. The lymphoblastoid cell lines (LCL) derived by
Epstein-Barr immortalization were LCL-N, LCL-N1, and LCL-N2 from healthy
individuals, AT52RM from an AT patient, 524RM and 227RM from two AT
heterozygotes, 1548 from an Italian NBS patient (47), and NBS02LA, NBS03LA,
and NBS04LA from three unrelated NBS patients (12). The lymphoblastoid cells
GM07078 (NBS patient) and GM08036 and GM08037 (NBS-heterozygous par-
ents) were obtained from the Coriell Cell Repository (Camden, N.J.). FB-N and
18ATRM are established fibroblasts from a healthy individual and an AT pa-
tient, respectively. GM07166 fibroblasts are established from the same NBS
patient as GM07078; ILB1 are simian virus 40-immortalized NBS fibroblasts,
GM07166/NBS1 are fibroblasts stably transfected with the full-length NBS1
cDNA, GM07166/s590 are stably transfected cells with the NBS1 cDNA trun-
cated at codon 590, and ILB1/S343A cells are stably transfected with Nbs1 with
a serine-to-alanine change at aa 343. The LCL were cultured in RPMI 1640
medium (BioWhittaker, Walkersville, Md.) supplemented with 15% heat-inac-
tivated fetal calf serum, penicillin (100 U/ml), and streptomycin (100 mg/ml),
while the fibroblasts were maintained in Dulbecco modified Eagle medium with
the same serum and antibiotic concentrations. Stable cells transfectants were
selected in medium containing hygromycin B (Boehringer, Mannheim, Ger-
many) at 200mg/ml and maintained in the presence of the drug at 100 mg/ml.
Cells were g irradiated in an IBL437CO instrument with a 137 Ce source emitting
a dose rate of 8 Gy/min.
Immunoblot analysis. Untreated or treated cells were washed with phosphate-
buffered saline plus 0.1 mM Na3VO4 (Sigma), pelleted, and lysed in Laemmli
buffer (0.125 M Tris-HCl [pH 6.8], 5% sodium dodecyl sulfate [SDS]) containing
as inhibitors 1 mM phenylmethylsulfonyl fluoride (PMSF), pepstatin (10 mg/ml),
aprotinin (100 KIU/ml), leupeptin (10 mg/ml) (all from Calbiochem, San Diego,
Calif.) and 1 mM Na3VO4. Lysates were boiled for 2 min, sonicated, and quan-
titated by the micro-bicinchoninic acid method (Pierce, Rockford, Ill.). Aliquots
containing proteins (10 to 50 mg/ml) plus 5% b-mercaptoethanol were size
fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) 7 to 10% gels
and electroblotted onto polyvinylidene difluoride membranes (Millipore, Bed-
ford, Mass.). After blocking with 5% nonfat dried milk in phosphate-buffered
saline plus 0.1% Tween (Sigma), the membranes were incubated with rabbit
antibodies specific for Chk2 (46) and Nbs1 (Novus Biologicals, Littleton, Cols.)
and subsequently with peroxidase-conjugated secondary antibodies. The immu-
noreactive bands were visualized by ECL Super Signal (Pierce) on autoradio-
graphic films. Autoradiographic bands were analyzed by optical densitometry
using a DuoScan system (Agfa, Mortsel, Belgium) and ImageQuant software
(Molecular Dynamics, Sunnyvale, Calif.).
IF. Cytospin preparations were stained by indirect immunofluorescence (IF)
as reported previously (26), using 1:50 to 1:100 dilutions of rabbit antibodies
specific for Nbs1 and Mre11 (both from Novus Biologicals). IF for Chk2 was
performed on cytospins fixed for 10 min in 2% paraformaldehyde, washed in
Tris-buffered saline, permeabilized with 0.1% Triton X-100, and incubated with
1:50 dilution of a rabbit anti-Chk2 antibody (Santa Cruz Biotech, Santa Cruz,
Calif.). The specificity of this antibody was verified in IF analysis by competition
with a recombinant full-length Chk2 protein. A normal rabbit serum was used as
a negative control. Binding of primary antibodies was revealed with a fluorescein
isothiocyanate-labeled F(ab)2 goat anti-rabbit antibody (1:50 dilution). Cover-
slips were mounted with an antifade solution containing the DNA counterstain
49,6-diamidino-2-phenylindole (DAPI). Images were collected with a Zeiss Ax-
ioskop (Germany) fluorescence microscope and digital imaging.
Immunoprecipitations and kinase reaction. Cells were lysed for 30 min in
ice-cold buffer containing 50 mM Tris-HCl (pH 7.4), 0.2% Triton X-100, 0.3%
NP-40, 150 mM NaCl, 1 mM PMSF, pepstatin (1 mg/ml), leupeptin (2 mg/ml),
aprotinin (2 mg/ml), 25 mM NaF, 1 mM EDTA, and 1 mM Na3VO4. The clarified
lysates were precleared with 10 ml of immobilized protein A (Sigma) for 10 min
at 4°C and immunoprecipitated with 5 mg of anti-Chk2 antibody and 10 ml of
immobilized protein A at 4°C for 2 h. Chk2 activity was assayed at 30°C for 30
min in a 20-ml reaction mixture containing 50 mM HEPES (pH 8.0), 10 mM
MgCl2, 2.5 mM EDTA, 1 mM dithiothreitol, 10 mM b-glycerophosphate, 1 mM
NaF, 0.1 mM Na3VO4, 0.1 mM PMSF, 10 mM ATP, and 30 mCi of [g-32P]ATP
and, when necessary, using a glutathione S-transferase (GST)–Cdc25C fragment
as a substrate (46). The reaction products were separated by SDS-PAGE, auto-
radiographed, and Western blotted for Ckh2 to verify the amount of immuno-
precipitated Chk2 per sample.
Mitotic index. The analysis were performed as described elsewhere (2).
Briefly, lymphoblastoid cells, unirradiated or irradiated with 1.5 Gy, were col-
lected at hourly intervals, washed with 0.075 M KCl, and after cytocentrifugation
onto glass slides, fixed in methanol-acetic acid (3:1) and stained for 5 min with
diluted Giemsa stain (BDH, Poole, England). Fibroblasts were plated on sterile
coverslips contained in petri dishes 2 days prior to irradiation and then processed
as described above. In all cases, no mitotic-phase-arresting agents were used.
Nuclei were counted by light microscope from at least 1,000 cells from each slide
preparation. For each time point, the fraction of mitotic cells present in the
unirradiated sample were normalized to 100%; the mitotic index indicates the
variation (in percentage) of mitotic figures present in the irradiated sample
counterpart.
RESULTS
ATM-dependent Chk2 phosphorylation in normal cell lines.
Shifts in Chk2 electrophoretic mobility reflect modifications of
its phosphorylation status (5, 27). We performed time course
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Western analysis on extracts from exponentially growing cell
lines to monitor the phosphorylation of Chk2 after 4 Gy of IR.
In four different cell lines, two normal LCL (LCL-N1 and
LCL-N2), a normal fibroblast (FB-N), and a breast cancer with
apparently normal ATM-dependent radiation response (MCF-
7), Chk2 showed an electrophoretic mobility delay at 30 min,
which increased further at 3 h post-IR, compared to unirradi-
ated controls (Fig. 1A). In a more detailed time course analysis
on LCL-N cells, Chk2 showed a maximum migration delay
between 1 and 3 h post-IR; 10 h later it started migrating
faster, reverting to the basal level at 72 h (Fig. 1B). As the
electrophoretic retardation of Chk2 is due to phosphorylation
since it can be eliminated by treatment with phosphatases
(reference 27 and our data not shown), these results indicate
that the full phosphorylation of Chk2 occurs within 1 h of IR
and appears to involve most, if not all, Chk2 molecules. Of
note, the Chk2 phosphorylation changes seen in the early
hours post-IR were not due to a cell cycle phase redistribution,
according to flow cytofluorimetric analysis (data not shown).
As in budding and fission yeast, the activation of Rad53 and
Cds1 is dependent on the ATM homologs Mec1 and Rad3,
respectively, and the same is true in mammalian cells (5, 8, 27)
we analyzed the regulation of Chk2 in the AT-derived cell line
AT52RM, negative for ATM protein expression (10). In this
AT cell line, and in contrast to LCL-N, no Chk2 phosphory-
lation was seen at any time point post-IR (Fig. 1C), thus con-
firming previous results and validating that the experimental
conditions used here allow to detect ATM-dependent Chk2
phosphorylation changes. To assess whether a reduced expres-
sion of ATM affects Chk2, we analyzed the AT-heterozygous
cell line 227RM, which exhibits 30% of the normal levels of
ATM protein (10). The IR-induced phosphorylation of Chk2
in this cell line was normal (Fig. 1C). Altogether, these findings
demonstrate that Chk2 is rapidly phosphorylated after low-
dose DNA damage in an ATM-dependent manner and even in
an ATM-haploinsufficient background.
Nbs1-dependent Chk2 phosphorylation. The overlapping
cellular abnormalities between AT and NBS prompted us to
determine the impact of Nbs1 deficiency on Chk2 regulation.
The NBS-derived LCL 1548 and GM07078A, homozygous for
truncation mutations of the NBS1 gene (835de14 and 657de15,
respectively) (7, 47, 49) were, unlike normal and AT cells,
negative for Nbs1 protein (Fig. 2A). In these NBS cells, and in
contrast to normal cells, Chk2 failed to show any electro-
phoretic mobility shift at 30 min after IR (Fig. 2B and C),
whereas at 3 h it evidenced a modest shift which suggested that
a small fraction of Chk2 molecules may have undergone phos-
phorylation at this time point. Collectively, these findings dem-
onstrate a marked impairment in NBS cells of IR-induced
Chk2 phosphorylation and lend support to the role of Nbs1 in
the rapid and sustained phosphorylation of this kinase. Of
note, Chk2 phosphorylation after IR was normal in two NBS-
heterozygous carriers (Fig. 2D) expressing .45% of the nor-
mal Nbs1 levels (data not shown), indicating that like the case
FIG. 1. Time course analysis of Chk2 phosphorylation following
exposure to low-dose IR. Western blotting was performed on expo-
nentially growing LCL-N, LCL-N1, LCL-N2, and FB-N normal cells
and MCF7 breast cancer cells (A) and (B) and on the AT and AT-
heterozygous (het.) cell lines AT52RM and 277RM (C). Cells were
harvested before or at various time points after 4 Gy of IR. Note the
progressive increase in Chk2 retardation in the early hours post-IR in
normal but not AT cells. This retardation is no longer seen in normal
cells at 72 h post-IR.
FIG. 2. Nbs1 protein expression and time course analysis of Chk2 phosphorylation in NBS cells. Western blotting was performed on normal
(LCL-N), AT (AT52RM), NBS (1548 and GM07078), and NBS-heterozygous (het.; GM08036 and GM08037) cells harvested before or at various
times after 4-Gy IR. (A) Samples tested for Nbs1 and normalized for b-actin. Note the absence of Nbs1 protein in the two NBS cell lines. (B to
D) Samples tested for Chk2. Note the absence of mobility shift 30 min post-IR in NBS cells but not in NBS-heterozygous cells.
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for ATM, NBS1 haploinsufficiency has no effect on Chk2 re-
sponses.
To verify that the defective Chk2 regulation in NBS cells was
entirely due to Nbs1 protein deficiency rather than to other
genetic defects, we analyzed Chk2 in NBS cells complemented
with wild-type NBS1. The ectopic expression of NBS1 in
GM07166/NBS1 and ILB1/NBS1 cells was confirmed by im-
munoblotting (Fig. 3). To further define the role of NBS1 in
this response, we analyzed NBS cells transfected with an NBS1
cDNA encoding a protein truncated at aa 590 (GM07166/s590)
that deletes the carboxy-terminus region containing the Mre11
binding domain (45). We also analyzed an Nbs1 mutant con-
taining a serine-to-alanine change at position 343 (ILB1/
S343A). Nbs1 Ser343 is directly phosphorylated by ATM im-
mediately after DNA damage, and mutations of this residue
only partially complement the S-phase checkpoint in NBS cells
(12, 24). These mutants, which demonstrated on immunoblots
Nbs1 proteins of the expected molecular size (Fig. 3), were also
characterized for Nbs1, Mre11, and Chk2 expression by IF of
cytospin preparations to determine the relationship between
NBS1 status, Nbs1 complex formation, and Chk2 localization.
Nbs1 protein, undetectable in NBS cells (Fig. 4, left panel, E
and F), demonstrated a nuclear fluorescence both in normal
cells (A and B) and in NBS cells ectopically expressing wild-
type (C and D) or mutant s590 (G and H) and S343A (I and L)
Nbs1 proteins. Mre11 (Fig. 4, middle panel) was nuclear in
normal cells (A and B) and NBS cells ectopically expressing
wild-type (C and D) or S343A (I and L) Nbs1, whereas it
showed a diffuse and cytoplasmic fluorescence in NBS and (E
and F) and in NBS/s590 (G and H) cells, the latter finding
demonstrating that the C-terminal region of Nbs1 is necessary
for the nuclear localization of the Nbs1-Mre11-Rad50 complex
(45). The nuclear Chk2 expression found in normal cells was
retained in NBS cells, whether or not transfected with the
various Nbs1 mutants (Fig. 4, right panels), and even 8 h after
IR (not shown). These findings would thus exclude a defect in
Chk2 localization as the cause of its failed phosphorylation in
NBS cells.
In contrast to parental or mock-transfected cells, NBS cells
ectopically expressing wild-type NBS1 (GM07166/NBS1 and
ILB1/NBS1) showed a restoration of Chk2 phosphorylation in
response to 4 Gy of IR (Fig. 5A and B). Neither s590 nor
S343A Nbs1 mutants were able to complement the Chk2 phos-
phorylation defect (Fig. 5C).
Collectively these data demonstrate that Chk2 phosphoryla-
tion is Nbs1 dependent, since in Nbs1-null NBS cells this event
is largely impaired but can be complemented with wild-type
Nbs1. Our data additionally indicate that the phosphorylation
of Chk2 requires the expression of a functional, ATM-phos-
phorylatable Nbs1 protein and the nuclear localization of the
Nbs1 complex.
FIG. 3. Nbs1 expression in NBS-transfected cells. Lysates from the
NBS fibroblast cell lines GM07166/NBS1, ILB1/NBS1, GM07166/s590,
and ILB1/S343A were Western blotted for Nbs1 to verify ectopic
expression of the NBS1 cDNA constructs. Blots were reprobed for
b-actin to normalize lanes for protein content.
FIG. 4. Nbs1, Mre11, and Chk2 localization in NBS-transfected cells. Normal fibroblasts (A and B), NBS cells (E and F), and NBS cells stably
expressing full-length Nbs1 (C and D), carboxy-truncated Nbs1(s590) (G and H), or S343A Nbs1 (I and L) were analyzed. The negative control
for each antibody, tested on normal fibroblasts, is shown (M and N). Green and blue color images represent IF labeling and DAPI nuclear DNA
staining, respectively.
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Nbs1-dependent Chk2 kinase activity. The catalytic activity
of Chk2 in relation to its phosphorylation status was examined
in vitro on Chk2 immunoprecipitates extracted from normal
and NBS cells before, 30 min after, and 3 h after 4 Gy of IR
and assayed for phosphorylation of the target residue Ser216
of Cdc25C. In normal cells, the basal Chk2 kinase activity
increased up to ;5-fold at 3 h but not at 30 min after IR
treatment (Fig. 6A). Conversely, in NBS cells Chk2 kinase
activity did not increase at any time point after IR. Western
blots of the kinase reactions verified the presence of similar
amounts of Chk2 protein (Fig. 6A). Importantly, the ectopic
expression in NBS cells of wild-type Nbs1 restored not only the
phosphorylation (as shown above) but also the catalytic activity
of Chk2 to almost the same extent as in normal cells (Fig. 6A),
suggesting that Nbs1 is necessary for the phosphorylative ac-
tivation of Chk2 by IR. Moreover, the finding that Chk2 kinase
activity does not increase in normal cells at 30 min and in NBS
cells at 3 h post-IR, when Chk2 shows a modest phosphoryla-
tion, (Fig. 2B) suggests that the activation of Chk2 depends on
multiple phosphorylation steps.
In S. cerevisiae, the activation of the Chk2 homolog Rad53
by DNA damage involves an initial phosphorylation by Mec1
(the homolog of human ATM) and autophosphorylation there-
after (34). Like Rad53, human Chk2 undergoes autophosphor-
ylation in vitro after DNA damage (5, 27, 46). To establish
whether this event occurs in NBS cells, Chk2 immunoprecipi-
tates from unirradiated and 4-Gy-irradiated cells were kinase
assayed in the absence of target substrate. Under these condi-
tions, both normal and NBS cells exhibited 30 min after IR a
Chk2 autophosphorylation signal whose intensity at 3 h de-
clined in the former cells but persisted in the latter (Fig. 6B).
Conversely, in AT cells no Chk2 autophosphorylation signal
was seen after IR (Fig. 6B), thus verifying the ATM depen-
dence of this event. These results indicate that Nbs1 deficiency
does not impair the initial steps of Chk2 activation leading to
its autophosphorylation and suggest that Nbs1 could regulate
subsequent phosphorylation events necessary for Chk2 to gain
in trans activity.
Chk2 phosphorylation after high-dose IR. Whereas low
doses of IR activate Chk2 in a ATM-dependent manner, high
doses of IR activate Chk2 independently of ATM (5, 8, 27).
Therefore, we analyzed Chk2 phosphorylation in NBS cells
exposed to 50 Gy of IR to determine Nbs1 dependence of this
modification. In contrast to the findings observed after 4 Gy of
IR, the time-dependent phosphorylation of Chk2 in NBS cells
progressed as in normal LCL-N and AT cells (Fig. 7), indicat-
ing that Chk2 activation becomes NBS independent (and ATM
independent) following large-scale DNA damage.
The G2/M checkpoint is defective in NBS cells. Upon acti-
vation by DNA damage, Chk2 phosphorylates Ccd25C, which
interferes with Cdc25C’s ability to dephosphorylate and acti-
vate the mitotic kinase Cdc2 (19, 25, 58). This event is thought
to block the progression from G2 to M phase, perhaps in
cooperation with other molecules signaling along the same
checkpoint pathway (e.g., Chk1) (55). On the basis of these
findings, we measured the time-dependent delay in progression
to mitosis after low-dose (1.5-Gy) IR to determine the possible
correlation in NBS cells between defective Chk2 activation and
alterations of the G2/M checkpoint. In normal cells, within 1 h
of IR, the mitotic index came down to less than 20%, com-
pared to 100% before irradiation, whereas in NBS cells, as in
AT cells, this value was around 70 to 80% (Fig. 8A). Within 2 h
of IR, the mitotic index in normal cells dropped to 0% but in
NBS and AT cells was significantly higher (30 to 40%), indi-
cating that like AT, NBS cells do not stop their entry into
mitosis immediately after irradiation. The failure of AT cells to
suppress the mitotic index after IR is concordant with previous
results (2). Importantly, the G2/M transition defect in NBS
FIG. 5. Chk2 mobility shifts in transfected NBS cells. Exponentially growing normal (FB-N) and NBS (GM07166 and ILB1/mock) fibroblasts
(A) and NBS fibroblasts ectopically expressing either full-length NBS1 cDNA (GM07166/NBS1 and ILB1/NBS1) (B), a C-terminal deletion
(GM07166/s590), or an S343A mutation (ILB1/S343A) (C) were harvested before or at the indicated time points after 4 Gy of IR and examined
on Western blots for Chk2.
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could be complemented by wild-type Nbs1 but only slightly by
the S343A Nbs1 mutant (Fig. 8B), underscoring the depen-
dence of this event on Nbs1.
Collectively, these findings highlight a defective G2/M tran-
sition in NBS cells. Given that ectopically expressed Nbs1
rescues this defect as well as the function of Chk2 (as shown
above), these results establish a link between Nbs1 and Chk2 in
G2/M checkpoint control.
FIG. 6. In vitro Chk2 kinase activity and autophosphorylation. Chk2 was immunoprecipitated (IP) from normal cells, NBS cells (GM07078 and
ILB1/mock), and NBS cells ectopically expressing wild-type Nbs1 (ILB1/NBS1) exposed or not to 4 Gy of IR. Kinase reactions were assayed on
GST-Cdc25C substrate, separated by gel electrophoresis, autoradiographed, and then Western blotted (WB) for Chk2 to verify the amount of
immunoprecipitated protein per sample (A). Chk2 autophosphorylation was examined in kinase assays performed without target substrate (B). The
graphs were obtained by the densitometric analysis of autoradiographic bands, as described in Materials and Methods, from three independent
experiments. The reported kinase values were normalized for immunoprecipitated Chk2 content in each lane.
VOL. 21, 2001 Chk2 ACTIVATION AND Nbs1 DEPENDENCE 5219
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
DISCUSSION
Eukaryotic cells respond to DNA damage by delaying cell
cycle progression through the activation of checkpoint path-
ways, in order to assess and repair the genetic lesions and to
prevent replication of cells which have lost their genome in-
tegrity (52, 57). In this study, we have examined the ATM-
dependent DNA damage response pathway in relation to the
role of Nbs1 in the activation of Chk2, a protein kinase that
regulates cell cycle checkpoints. ATM and NBS1 are the genes
responsible for AT and NBS, respectively, two disorders that
share hypersensitivity to genotoxic agents, immunodeficiency,
and increased predisposition to cancer. ATM is a protein ki-
nase which upon activation by double-strand breaks (16) phos-
phorylates several target proteins (e.g., p53, Chk2, MDM2,
RPA, BRCA1, and c-Ab1) (20) that are crucial for the regu-
lation of checkpoint arrest and DNA repair (22). Nbs1 is a
component of the multifunctional protein complex containing
Mre11 and Rad50, involved in recognition and processing of
DNA lesions (33, 36). Several lines of evidence suggest a func-
tional link between these proteins, including the common
G2/M checkpoint defect exhibited by the associated diseases
(2, 15, 44), the DNA damage-induced phosphorylation of Nbs1
by ATM (12, 24, 53, 56), and their physical association in the
BRCA1-associated supercomplex (50).
The protein kinase Chk2 is phosphorylated and activated in
response to IR (27), following which it can phosphorylate the
mitotic phosphatase Cdc25C on an inhibitory site, thereby pre-
venting mitotic entry (37). Chk2 can also phosphorylate the
p53 oncosuppressor protein on Ser20 regulatory site, thus
causing G1 arrest (8, 14, 40). Furthermore, p53 can in turn
negatively regulate the transcription of Chk2 (46). Interest-
ingly, the oncosuppressor protein BRCA1, the core of the
BRCA1-associated supercomplex, physically interacts with
Chk2 protein and is also a putative target of Chk2 activity (23).
In this study we have demonstrated, on the basis of the
electrophoretic mobility changes on gels, a progressive time-
dependent phosphorylation of Chk2 after IR that becomes
maximal between 1 and 3 h and persists for up to 10 h. As Chk2
contains seven putative major phosphorylation sites, consid-
ered responsible for electrophoretic mobility delay after IR
(28, 30), these findings suggest that these residues are not
simultaneously modified.
The typical Chk2 phosphorylation after 4-Gy IR was ATM
and NBS1 dependent, as it was found to be defective in both
AT and NBS cells. It should be noted, however, that in NBS
cells Chk2 showed a minor mobility shift at 3 h post-IR, sug-
gesting that at this time point a limited and transient phos-
phorylation may occur in a fraction of the Chk2 pool of mol-
ecules. As Chk2 revealed the same nuclear immunostaining
pattern in both normal and NBS cells, we can exclude a mis-
localization phenomenon as the cause for defective Chk2 phos-
phorylation in Nbs1-deficient cells. We have also shown that
decreased expression of ATM or Nbs1 protein does not impair
the phosphorylation of Chk2, according to the analysis of AT-
or NBS-heterozygous cells. The normal behavior of AT-het-
erozygous cells is intriguing since quite often other ATM-
dependent events, such as apoptosis or spindle checkpoint
control, are compromised in these cells (42).
As Chk2 phosphorylation leads to its enzymatic activation
(28), we assayed Chk2 kinase in vitro at different time points
after IR. In these experiments, only the hyperphosphorylated
form of Chk2 present in normal cells between 1 and 3 h showed
enhanced kinase activity toward Cdc25C substrate, whereas
the phosphorylated forms of Chk2 present in normal cells at 30
min and in NBS cells at 3 h showed basal activity only. There-
fore, the radiation-induced Chk2 activity in NBS cells is, as in
AT cells, completely defective.
To provide evidence for a direct relationship between im-
paired Chk2 activity and Nbs1 deficiency, we complemented
NBS cells with wild-type NBS1 and demonstrated that Chk2
phosphorylation and kinase activity are both restored after IR.
FIG. 7. Chk2 mobility shifts in response to high doses of IR. Nor-
mal, AT, and NBS cells were harvested before or after exposure to 50
Gy of IR and Western blotted for Chk2. Note the similar IR-induced
Chk2 gel retardation in all cell lines, indicating an ATM- and NBS-
independent Chk2 phosphorylation event.
FIG. 8. Mitotic index delay in irradiated NBS cells. Cells, treated or not with 1.5 Gy of IR, were collected at hourly intervals, fixed, and stained
as detailed in Materials and Methods. No mitotic-phase-arresting agents were used. Mitotic nuclei were counted by microsopy from at least 1,000
cells from each sample. For each time point, the fraction of mitotic cells present in the unirradiated sample was normalized to 100%, and the
mitotic index indicates the percentage change in mitotic figures present in the irradiated sample counterpart.
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Noteworthy, Chk2 phosphorylation was restored neither by an
Nbs1 mutant protein truncated at a 590, which deletes the
Mre11 binding domain (45), nor by a mutant in Ser343
(S343A), the ATM phosphorylation site. Mutants in Ser343
only partially complement S-phase checkpoint in NBS cells
(24). Together with the other results, these findings indicate
that radiation-induced activation Chk2 requires a correctly lo-
calized and phosphorylation-activated Nbs1 complex.
In S. cerevisiae, the activation of the Chk2 homolog Rad53
occurrs by two interdependent steps, the first involving phos-
phorylation by Mec1 (the homolog of human ATM) and the
second involving an autophosphorylation process (34). Evi-
dence for the autophosphorylation of Chk2 in vitro in response
to IR has been recently provided (5, 27, 46). Here we have
shown that, unlike in AT cells, Chk2 undergoes autophosphor-
ylation in normal and NBS cells, even at the time point when
it appears modestly phosphorylated and catalytic inactive
against Cdc25C substrate (e.g., at 30 min and 3 h post-IR in
normal and NBS cells, respectively). Hence, in light of these
findings, it is conceivable that low doses of IR elicit an in trans
phosphorylation of Chk2 by ATM followed by autophosphor-
ylation and thereafter by other phosphorylation events sus-
tained by Nbs1. These data, additionally, seem to temporally
separate the in trans and in cis activities of Chk2. However, we
cannot exclude the participation of another kinase that may
potentially cooperate with ATM in Chk2 phosphorylation.
To better characterize the NBS1- and ATM-dependent
Chk2 response in relation to the amount DNA damage, we
examined this kinase in AT and NBS cells exposed to high
doses of g radiation. We showed that under these conditions
Chk2 undergoes phosphorylation in an NBS- and ATM-inde-
pendent manner. Whether this arises from the activity of ATR,
an ATM-related protein kinase whose function partly overlaps
with that of ATM, cannot be excluded. In this regard, it is
worth noting that the closest human homolog of S. pombe
Rad3, the modulator of the Chk2 homolog Cds1, is ATR (4).
In any case, the finding that ATM and NBS1 are either in-
volved or not in the activation of Chk2, depending on the
extent of DNA damage, agrees with a cooperative role of Nbs1
and ATM in a DNA damage signal transduction pathway.
Data in the literature indicate that changes in p53 protein
levels in NBS-derived lymphoblastoid and fibroblast cell lines
exposed to low-dose IR are significantly reduced and delayed
relative to normal cells (1, 17, 55). Given that Chk2 phosphor-
ylates p53 on Ser20, an event that contributes to disrupt the
interaction of p53 with MDM2, thereby allowing the p53 pro-
tein to accumulate, these observations suggest a relationship in
NBS cells between defective accumulation of p53 and impaired
activation of Chk2.
The arrest of mammalian cells at the G2/M checkpoint in-
volves inactivation of Cdc25C by phosphorylation on Ser216,
which intereferes with Cdc25C’s ability to activate the mitotic
kinase Cdc2. As both Chk1 and Chk2 can phosphorylate
Cdc25C on Ser216 (18, 27), the contribution of each of these
kinases in G2-to-M-phase transition arrest is unclear. Never-
theless, Chk2 appears to have a role, based on the findings that
inhibition of the ATM-Chk2 pathway by caffeine abolishes the
G2/M DNA damage checkpoint (58) and that Chk2
2/2 embry-
onic stem cells fail to maintain IR-induced arrest in G2 phase
of the cell cycle (14). These findings led us to consider the
possibility that the G2/M checkpoint in NBS cells might be
impaired because of the defective Chk2 activation. We have
shown that in contrast to normal cells, NBS cells fail to stop
entry into mitosis immediately after irradiation, strongly sug-
gesting that Nbs1 deficiency disrupts the G2/M checkpoint. In
this respect, NBS appear to behave like AT cells null for ATM
(2). Importantly, the G2/M checkpoint defect in NBS cells can
be rescued by reintroduction of wild-type Nbs1 but only slightly
by S343A, a mutant in the ATM phosphorylation site which
fails to restore the S-phase checkpoint in NBS cells (12, 24).
These findings, and the fact that ectopic Nbs1 expression com-
pensates for both Chk2 and mitotic arrest defects, establish a
link between these two molecules in G2/M checkpoint control.
Collectively, our results support a model whereby the coop-
eration between ATM and Nbs1 is an essential condition for
the rapid and sustained activation of Chk2 checkpoint kinase
in response to DNA damage. Although the mechanism for the
dependence of Chk2 phosphorylation on Nbs1 remains un-
clear, our biochemical studies provide as yet no evidence for
a physical association between these molecules (data not
shown), hence suggesting a more complex regulatory interac-
tion. Finally, our study provides insight for the better under-
standing of checkpoint defects in NBS cells.
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